Client
Janssen
Platforms
iPad
Outcome
The tool was successfully completed and delivered, and is already used in the field by sales reps as well as having been presented at several congresses.
Project Definition
Janssen Pharmaceutica is a pharmaceutical company headquartered in Beerse, Belgium. Janssen is one of the world’s leading research-based pharmaceutical companies and part of the Johnson & Johnson family of companies, which is the largest diversified healthcare group in the world.
Imbruvica is a small molecule drug that binds permanently to a protein, Bruton’s tyrosine kinase, that is important in B-cells. It is used to treat B-cell cancers like mantle cell lymphoma, chronic lymphocytic leukaemia (CLL), and Waldenström’s macroglobulinemia.
The client requested that an eDetail be produced to reflect the need to create a bridge between the core IMBRUVICA message and 5 patient indications. Our target group is haematologists and oncologists via sales reps.
The Challenge
The scope of this work was the development of digital content, the creation of digital interactive objects, and the preparation of an application that connected to the CMS. The eDetail aid was to be revised based on new IMBRUVICA data.
One of our main objectives was to keep customers up-to-date on the latest IMBRUVICA data and reinforce the durability of IMBRUVICA efficacy across indications with longer-term results.
My Role
I created information architecture based on a content framework, a sitemap, an interactive online prototype, and functional specification documents for development.
The Approach
The navigational approach was based on a native CMS, with left/right swipes through core sections and additional content accessible via CTAs.
In order to use the tool effectively within a limited presentation time for HCPs, we created clear, easy-to-understand visual language with smooth animations and interactions in order to reduce cognitive load. Application prepared on iPad
Problems and Solutions
The sector-specific regulations, content limitations, the existence of highly technical data, and clients’ strict guidelines were the main challenges we had to address. With the talented subject-matter experts, we successfully completed and delivered the product. It is already in use in the field by sales reps and has also been presented at several congresses.
